Clinical Trials
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
S0424
Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men
Research Committee(s)
Lung Cancer
Molecular Epidemiology
Activated
10-01-2005
Closed
03-15-2011
Closed
Phase
Accrual
0%
SWOG Clinical Trial Number
S0511
A Phase II Study of Goserelin Plus Anastrozole for the Treatment of Male Patients With Hormone-Receptor Positive Metastatic or Recurrent Breast Cancer"
Research Committee(s)
Breast Cancer
Activated
09-15-2005
Closed
01-10-2007
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0350
Phase II Trial of Cisplatin Plus Etoposide Plus Gemcitabine Plus Solumedrol (PEGS) in Peripheral T-Cell Non-Hodgkin's Lymphoma
Research Committee(s)
Lymphoma
Activated
09-15-2005
Closed
12-01-2010
Closed
Phase
Accrual
77%
Published
SWOG Clinical Trial Number
S0517
A Phase II Trial of Suberoylanilide Hydroxamic Acid (NSC-701852) for Recurrent or Primary Refractory Hodgkin's Lymphoma -
Research Committee(s)
Lymphoma
Activated
09-15-2005
Closed
08-01-2007
Closed
Phase
Accrual
19%
SWOG Clinical Trial Number
S0423
Phase II Trial of Pemetrexed for Advanced Chondrosarcomas
Research Committee(s)
Sarcoma
Activated
09-01-2005
Closed
01-15-2007
Closed
Phase
SWOG Clinical Trial Number
S0334
Cytogenetic and Fluorescence In Situ Hybridization Studies in Multiple Myeloma
Research Committee(s)
Myeloma
Activated
09-01-2005
Closed
06-15-2007
Closed
Phase
Accrual
53%
SWOG Clinical Trial Number
S0437
Prostate Cancer Prevention Trial (PCPT) Companion Long Term Follow Up Study for Men Diagnosed with Prostate Cancer
Research Committee(s)
Genitourinary Cancer
Activated
09-01-2005
Closed
03-01-2009
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0430
Phase II Trial of Simple Oral Therapy (Continuous Oral Cyclophosphamide and Capecitabine) in Patients With Metastatic Breast Cancer
Research Committee(s)
Breast Cancer
Activated
08-15-2005
Closed
09-01-2007
Closed
Phase
Accrual
8%
SWOG Clinical Trial Number
S0417
A Phase II Study of Bortezomib (Velcade™, PS-341), Thalidomide, and Dexamethasone in Patients With Refractory Multiple Myeloma
Research Committee(s)
Myeloma
Activated
08-01-2005
Closed
06-15-2007
Closed
Phase
Accrual
0%
SWOG Clinical Trial Number
S0346
Phase II Study of Trastuzumab (NSC-688097) in Treatment of Locally Advanced or Metastatic Synovial Sarcoma
Research Committee(s)
Sarcoma
Activated
07-15-2005
Closed
12-01-2006
Closed
Phase
Accrual
2%
SWOG Clinical Trial Number
S0501
Nonmyeloablative Allogeneic Stem Cell Transplantation for Relapsed Hodgkin's or Non-Hodgkin's Lymphoma After Autologous Transplantation (A BMT Study)
Research Committee(s)
Lymphoma
Activated
07-01-2005
Closed
01-10-2007
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0435
A Phase II Trial of BAY 43-9006 (NSC-724772) in Patients with Platinum-Treated Extensive Stage Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
07-01-2005
Closed
02-15-2007
Closed
Phase
Accrual
13%
SWOG Clinical Trial Number
S0217
Adjuvant Chemo-Radiotherapy with Combination of Cisplatin (NSC-119875)and Docetaxel (NSC-628503) After Complete Resection of Locally Advanced (Stage III and IV) Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Research Committee(s)
Head and Neck Cancer
Activated
07-01-2005
Closed
01-10-2007
Closed
Phase
Accrual
9%
SWOG Clinical Trial Number
S0431
Phase II Study of Trastuzumab (NSC-688097) in Advanced High Grade Salivary Gland Carcinoma
Activated
07-01-2005
Closed
01-10-2007
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0515
Phase II Trial of Standard Dose Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) and Rituximab Plus Bevacizumab for Advanced Stage Diffuse Large B-Cell NHL
Research Committee(s)
Lymphoma
Activated
06-15-2005
Closed
09-15-2008
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0508
Phase II Trial of Combination Thalidomide plus Temozolomide in Patients with Metastatic Melanoma
Research Committee(s)
Melanoma
Activated
06-01-2005
Closed
01-01-2007
Closed
Phase
Accrual
29%
Published
SWOG Clinical Trial Number
S0414
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial with Molecular Correlates
Research Committee(s)
Gastrointestinal Cancer
Activated
05-01-2005
Closed
09-01-2007
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
S0333
Closed
Phase
Accrual
2%
SWOG Clinical Trial Number
S0340
A Prospective Observational Study of Patients with Solitary Plasmacytoma Using a Modified Staging System Supplemented by an MRI and Whole Body FDG-PET Scan
Research Committee(s)
Myeloma
Activated
04-15-2005
Closed
02-15-2007
Closed
Phase
Accrual
62%
Published
SWOG Clinical Trial Number
S0418
A Phase II Study of SB-715992 (NSC-727990, IND-70273) in Taxane-Resistant Androgen-Independent Metastatic Prostate Cancer
Research Committee(s)
Genitourinary Cancer
Activated
04-01-2005
Closed
05-01-2006